Does infliximab treatment reduce complement activation in patients with rheumatoid arthritis?
Treatment with infliximab decreases plasma levels of CRP and CRP dependent complement activation products and concomitantly may reduce complement activation in RA. Complement activation may be among the effector mechanisms of TNF in RA.
Caudal epidural anesthesia provides effective postoperative analgesia similar to lumbar epidural anesthesia.